[go: up one dir, main page]

DK3322804T3 - Nuklease-uafhængigt målrettet genredigeringsplatform og anvendelser deraf - Google Patents

Nuklease-uafhængigt målrettet genredigeringsplatform og anvendelser deraf Download PDF

Info

Publication number
DK3322804T3
DK3322804T3 DK16825229.4T DK16825229T DK3322804T3 DK 3322804 T3 DK3322804 T3 DK 3322804T3 DK 16825229 T DK16825229 T DK 16825229T DK 3322804 T3 DK3322804 T3 DK 3322804T3
Authority
DK
Denmark
Prior art keywords
nuklease
applications
reduction platform
targeted reduction
independent targeted
Prior art date
Application number
DK16825229.4T
Other languages
English (en)
Inventor
Shengkan Jin
Juan-Carlos Collantes
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57758208&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3322804(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Rutgers filed Critical Univ Rutgers
Application granted granted Critical
Publication of DK3322804T3 publication Critical patent/DK3322804T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
DK16825229.4T 2015-07-15 2016-07-15 Nuklease-uafhængigt målrettet genredigeringsplatform og anvendelser deraf DK3322804T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562192876P 2015-07-15 2015-07-15
PCT/US2016/042413 WO2017011721A1 (en) 2015-07-15 2016-07-15 Nuclease-independent targeted gene editing platform and uses thereof

Publications (1)

Publication Number Publication Date
DK3322804T3 true DK3322804T3 (da) 2021-10-04

Family

ID=57758208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16825229.4T DK3322804T3 (da) 2015-07-15 2016-07-15 Nuklease-uafhængigt målrettet genredigeringsplatform og anvendelser deraf

Country Status (9)

Country Link
US (3) US11479793B2 (da)
EP (2) EP3957731A1 (da)
JP (2) JP7044373B2 (da)
CN (1) CN108291218B (da)
CA (2) CA3168241A1 (da)
DK (1) DK3322804T3 (da)
ES (1) ES2892625T3 (da)
HK (1) HK1258288A1 (da)
WO (1) WO2017011721A1 (da)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US20150166985A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting von willebrand factor point mutations
CA2956224A1 (en) 2014-07-30 2016-02-11 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
EP3957731A1 (en) 2015-07-15 2022-02-23 Rutgers, The State University of New Jersey Nuclease-independent targeted gene editing platform and uses thereof
JP7067793B2 (ja) 2015-10-23 2022-05-16 プレジデント アンド フェローズ オブ ハーバード カレッジ 核酸塩基編集因子およびその使用
CA3022319A1 (en) * 2016-05-06 2017-11-09 Tod M. Woolf Improved methods for genome editing with and without programmable nucleases
CN107522787A (zh) * 2016-06-15 2017-12-29 中国科学院上海生命科学研究院 在细胞内产生点突变的融合蛋白、其制备及用途
GB2568182A (en) 2016-08-03 2019-05-08 Harvard College Adenosine nucleobase editors and uses thereof
EP3497214B1 (en) 2016-08-09 2023-06-28 President and Fellows of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
GB2573062A (en) 2016-10-14 2019-10-23 Harvard College AAV delivery of nucleobase editors
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
EP3565608A4 (en) * 2017-01-05 2020-12-16 Rutgers, The State University of New Jersey TARGETED GENE EDITING PLATFORM INDEPENDENT OF BICATENARY DNA BREAKAGE AND ITS USES
EP3592381A1 (en) * 2017-03-09 2020-01-15 President and Fellows of Harvard College Cancer vaccine
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
US11845953B2 (en) 2017-03-22 2023-12-19 National University Corporation Kobe University Method for converting nucleic acid sequence of cell specifically converting nucleic acid base of targeted DNA using cell endogenous DNA modifying enzyme, and molecular complex used therein
US11268082B2 (en) 2017-03-23 2022-03-08 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable DNA binding proteins
CN107384920B (zh) * 2017-05-10 2020-07-14 中山大学 一套基于化脓性链球菌的碱基编辑系统及其在基因编辑中的应用
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
AU2018272067B2 (en) 2017-05-25 2024-07-18 The General Hospital Corporation Base editors with improved precision and specificity
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
US20190032053A1 (en) * 2017-07-31 2019-01-31 Sigma-Aldrich Co. Llc Synthetic guide rna for crispr/cas activator systems
WO2019139645A2 (en) 2017-08-30 2019-07-18 President And Fellows Of Harvard College High efficiency base editors comprising gam
EP3697906A1 (en) * 2017-10-16 2020-08-26 The Broad Institute, Inc. Uses of adenosine base editors
US20210180059A1 (en) * 2017-11-16 2021-06-17 Astrazeneca Ab Compositions and methods for improving the efficacy of cas9-based knock-in strategies
WO2019126709A1 (en) * 2017-12-22 2019-06-27 The Broad Institute, Inc. Cas12b systems, methods, and compositions for targeted dna base editing
EP3592140A1 (en) 2018-03-19 2020-01-15 Regeneron Pharmaceuticals, Inc. Transcription modulation in animals using crispr/cas systems
KR20210023831A (ko) 2018-05-11 2021-03-04 빔 테라퓨틱스, 인크. 프로그래밍가능한 염기 편집기 시스템을 이용하여 병원성 아미노산을 치환하는 방법
EP3797160A1 (en) 2018-05-23 2021-03-31 The Broad Institute Inc. Base editors and uses thereof
CN108949830B (zh) * 2018-08-03 2021-11-26 福州大学 一种在鱼类中实现基因组编辑、精确定点基因敲入的方法
CN110878321B (zh) * 2018-09-06 2023-08-22 上海科技大学 一种用于肺炎克雷伯菌基因编辑的表达载体
CN109385425A (zh) * 2018-11-13 2019-02-26 中山大学 一种高特异性ABE碱基编辑系统及其在β血红蛋白病中的应用
US20220106584A1 (en) * 2019-01-14 2022-04-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for generating and selecting a variant of a binding protein with increased binding affinity and/or specificity
WO2020163396A1 (en) 2019-02-04 2020-08-13 The General Hospital Corporation Adenine dna base editor variants with reduced off-target rna editing
WO2020168133A1 (en) 2019-02-13 2020-08-20 Beam Therapeutics Inc. Compositions and methods for treating hemoglobinopathies
WO2020191248A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Method and compositions for editing nucleotide sequences
US20220235348A1 (en) * 2019-05-15 2022-07-28 Board Of Regents, The University Of Texas System Crispr methods for treating cancers
EP4008784A1 (en) * 2019-08-01 2022-06-08 Astellas Pharma Inc. Guide rna for targeted-editing with functional base sequence added thereto
EP3783104A1 (en) * 2019-08-20 2021-02-24 Kemijski Institut Coiled-coil mediated tethering of crispr-cas and exonucleases for enhanced genome editing
CN112481309B (zh) * 2019-09-12 2023-10-10 石家庄埃佤基因科技有限公司 Ago蛋白的用途及组合物和基因编辑方法
WO2021081264A1 (en) 2019-10-24 2021-04-29 Pairwise Plants Services, Inc. Optimized crispr-cas nucleases and base editors and methods of use thereof
CN115038789A (zh) 2019-12-02 2022-09-09 塑造治疗公司 治疗性编辑
CA3173526A1 (en) * 2020-03-03 2021-09-10 The Board Of Trustees Of The Leland Stanford Junior University Rna-guided genome recombineering at kilobase scale
WO2021175289A1 (zh) * 2020-03-04 2021-09-10 中国科学院遗传与发育生物学研究所 多重基因组编辑方法和系统
EP4146804A1 (en) 2020-05-08 2023-03-15 The Broad Institute Inc. Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
EP4179079A1 (en) 2020-07-10 2023-05-17 Horizon Discovery Limited Method for producing genetically modified cells
EP4247951A2 (en) * 2020-11-19 2023-09-27 Wake Forest University Health Sciences Vectors, systems and methods for eukaryotic gene editing
JP2024502348A (ja) * 2021-01-05 2024-01-18 ホライズン・ディスカバリー・リミテッド Ｔｒａｃｒ不含 Ｖ型Ｃａｓシステム用のガイドＲＮＡデザインおよび複合体
CA3207094A1 (en) * 2021-01-05 2022-07-14 Horizon Discovery Ltd. Guide rna designs and complexes for type v cas systems
US20240067954A1 (en) 2021-01-05 2024-02-29 Horizon Discovery Limited Method for producing genetically modified cells
GB202107671D0 (en) 2021-05-28 2021-07-14 Asociacion Centro De Investig Cooperativa En Nanociencias Cic Nanogune Synthetic cas proteins
EP4347808A2 (en) 2021-05-25 2024-04-10 ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN NANOCIENCIAS "CIC nanoGUNE" Synthetic cas proteins
WO2024096790A1 (en) * 2022-10-31 2024-05-10 Soledits Ab Modular crispr system
CN116726198B (zh) * 2023-03-13 2024-02-13 陕西师范大学 一种抗肿瘤药物及其在脑胶质瘤治疗中的应用
WO2024196921A1 (en) 2023-03-20 2024-09-26 Pioneer Hi-Bred International, Inc. Cas polypeptides with altered pam recognition
WO2024238909A1 (en) * 2023-05-17 2024-11-21 William Marsh Rice University Programmable rna scaffolds for multivariate effector recruitment using crispr/cas

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US63258A (en) 1867-03-26 David king
US4625014A (en) 1984-07-10 1986-11-25 Dana-Farber Cancer Institute, Inc. Cell-delivery agent
US5061641A (en) 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins
US5057301A (en) 1988-04-06 1991-10-15 Neorx Corporation Modified cellular substrates used as linkers for increased cell retention of diagnostic and therapeutic agents
AU5670194A (en) 1992-11-20 1994-06-22 Enzon, Inc. Linker for linked fusion polypeptides
US6165476A (en) 1997-07-10 2000-12-26 Beth Israel Deaconess Medical Center Fusion proteins with an immunoglobulin hinge region linker
US20100063258A1 (en) 2006-06-28 2010-03-11 The Board Of Trustees Of The Leland Stanford Junior University Fusion protein constructs
EP2160396B1 (en) 2007-05-10 2018-11-21 Agilent Technologies, Inc. Thiocarbon-protecting groups for rna synthesis
US20110104787A1 (en) 2009-11-05 2011-05-05 President And Fellows Of Harvard College Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences
HUE033008T2 (hu) 2011-04-13 2017-11-28 Bristol Myers Squibb Co FC fúziós proteinek, amelyek tartalmaznak új linkereket
LT2800811T (lt) 2012-05-25 2017-09-11 The Regents Of The University Of California Būdai ir kompozicijos, skirti tikslinės dnr modifikavimui, panaudojant adresuotą rnr, ir transkripcijos moduliavimui, panaudojant adresuotą rnr
US9421245B2 (en) 2012-06-25 2016-08-23 The Brigham And Women's Hospital, Inc. Targeted therapeutics
US20140189896A1 (en) 2012-12-12 2014-07-03 Feng Zhang Crispr-cas component systems, methods and compositions for sequence manipulation
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
CN105121641A (zh) 2012-12-17 2015-12-02 哈佛大学校长及研究员协会 Rna-引导的人类基因组工程化
JP2016506541A (ja) 2012-12-18 2016-03-03 レンズヴェクター インコーポレイテッドＬｅｎｓｖｅｃｔｏｒ Ｉｎｃｏｒｐｏｒａｔｅｄ 高度な電界制御能力を備えた液晶光学装置
WO2014152432A2 (en) 2013-03-15 2014-09-25 The General Hospital Corporation Rna-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US20140273230A1 (en) 2013-03-15 2014-09-18 Sigma-Aldrich Co., Llc Crispr-based genome modification and regulation
US9234213B2 (en) 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
AU2014281027A1 (en) 2013-06-17 2016-01-28 Massachusetts Institute Of Technology Optimized CRISPR-Cas double nickase systems, methods and compositions for sequence manipulation
WO2015089486A2 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
US20150166985A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting von willebrand factor point mutations
CN113684205B (zh) * 2013-12-26 2024-11-12 通用医疗公司 多重引导rna
MX375420B (es) * 2014-02-11 2025-03-06 The Regents Of The Univ Of Colorado A Body Corporate Ingenieria genetica multiplexada habilitada por crispr.
PL3115457T3 (pl) * 2014-03-05 2020-01-31 National University Corporation Kobe University Sposób modyfikacji sekwencji genomowej do specyficznego przekształcania zasad kwasu nukleinowego docelowej sekwencji dna oraz kompleks molekularny do zastosowania w nim
WO2016054106A1 (en) 2014-09-29 2016-04-07 The Regents Of The University Of California SCAFFOLD RNAs
ES2731437T3 (es) 2014-11-21 2019-11-15 Regeneron Pharma Métodos y composiciones para la modificación genética dirigida mediante el uso de pares de ARN guías
US10190106B2 (en) 2014-12-22 2019-01-29 Univesity Of Massachusetts Cas9-DNA targeting unit chimeras
EP3957731A1 (en) 2015-07-15 2022-02-23 Rutgers, The State University of New Jersey Nuclease-independent targeted gene editing platform and uses thereof
JP7067793B2 (ja) 2015-10-23 2022-05-16 プレジデント アンド フェローズ オブ ハーバード カレッジ 核酸塩基編集因子およびその使用
EP3565608A4 (en) 2017-01-05 2020-12-16 Rutgers, The State University of New Jersey TARGETED GENE EDITING PLATFORM INDEPENDENT OF BICATENARY DNA BREAKAGE AND ITS USES
AU2018272067B2 (en) 2017-05-25 2024-07-18 The General Hospital Corporation Base editors with improved precision and specificity
JP2024534720A (ja) 2021-08-06 2024-09-25 ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー 遺伝子改変細胞を作製するための方法

Also Published As

Publication number Publication date
EP3957731A1 (en) 2022-02-23
CA2992580C (en) 2022-09-20
HK1258288A1 (zh) 2019-11-08
CA3168241A1 (en) 2017-01-19
JP7044373B2 (ja) 2022-03-30
JP2018520686A (ja) 2018-08-02
ES2892625T3 (es) 2022-02-04
EP3322804A4 (en) 2019-01-30
US20250101464A1 (en) 2025-03-27
US20180327784A1 (en) 2018-11-15
US20220267806A1 (en) 2022-08-25
CA2992580A1 (en) 2017-01-19
JP2022095633A (ja) 2022-06-28
WO2017011721A1 (en) 2017-01-19
US12188043B2 (en) 2025-01-07
JP7364268B2 (ja) 2023-10-18
CN108291218B (zh) 2022-08-19
US11479793B2 (en) 2022-10-25
CN108291218A (zh) 2018-07-17
EP3322804A1 (en) 2018-05-23
EP3322804B1 (en) 2021-09-01

Similar Documents

Publication Publication Date Title
DK3322804T3 (da) Nuklease-uafhængigt målrettet genredigeringsplatform og anvendelser deraf
DK3872085T5 (da) Stam-virussekvenser og anvendelser heraf
DK3448386T3 (da) Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf
DK3368534T3 (da) Valbenazin-ditosylat og polymorfer deraf
DK3310371T3 (da) Glucagon og GLP-1-Co-agonistforbindelser
DK3201351T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
DK3283106T3 (da) Terapeutiske antistoffer og anvendelser deraf
DK3265947T3 (da) Fremgangsmåde og system til kryptering
DK3212255T3 (da) Selvorienterende sprøjte og sprøjtegrænseflade
PL3265448T3 (pl) Proleki riluzolu i ich zastosowanie
DK3354282T3 (da) Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3155024T3 (da) Opholdsstrukturer og relaterede fremgangsmåder
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
DK3236991T3 (da) Fgf21-derivater og anvendelser deraf
DK3395801T3 (da) Arylazolforbindelse og skadedyrsbekæmpelsesmiddel
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf
DK3256598T3 (da) Svampestammer og anvendelsesfremgangsmåder
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3054744T3 (da) Lederforbindelse og lederforbindelseskomponent
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3375847T3 (da) Tungoliehydrering-behandlingssystem og tungoliehydrering-behandlingsfremgangsmåde
DK3280405T3 (da) Inhibitorer og anvendelser deraf
MA49905A (fr) Polyesteramines et polyesterquats